EMA accepts Merck’s MAA for cladribine tablets in multiple sclerosis
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its ...
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its ...
The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the ...
Shire plc announced it has agreed to license global rights to all indications for PF-00547659 from Pfizer Inc. ...
ViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg ...
Merck, a leading science and technology company, announced an increased commitment to its corporate venture fund under the new Merck ...
GlaxoSmithKline and Innoviva, Inc announced that GlaxoSmithKline plc (GSK) presented new data at the American Thoracic Society (ATS) Conference from ...
Allergan plc launched IBSDonTract.com, an online resource for those living with irritable bowel syndrome with diarrhea (IBS-D). IBS-D, which affects ...
Pfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for TRUMENBA® (Meningococcal Group B ...
• Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 ...
• 14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA, ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.